Herantis Pharma Plc’s Financial Calendar and Annual General Meeting in 2021
Herantis Pharma PlcCompany release 23 Dec 2020 at 09:00 am EET Herantis Pharma Plc (“Herantis”), an innovative drug development company pioneering new disease modifying and regenerative biologic and gene therapies, hereby publishes the financial calendar for 2021: · Quiet period before H2 & FY 2020 1 February – 3 March 2021 Report on H2 and FY 2020 3 March 2021 · Deadline for submission of proposals for the AGM 15 February 2021 · Annual Report for 2020